Healing America Through Innovation in Healthcare

Healthcare Innovation Journal

Subscribe to Healthcare Innovation Journal: eMailAlertsEmail Alerts newslettersWeekly Newsletters
Get Healthcare Innovation Journal: homepageHomepage mobileMobile rssRSS facebookFacebook twitterTwitter linkedinLinkedIn


Healthcare Innovation Authors: Progress Blog, LeanTaaS Blog, Yoel Knoll, Mark Hoover, Ram Sonagara

Related Topics: Wine Blog on Ulitzer

Wine: News Feed Item

Pernod Ricard is pleased to announce that it is retaining its Montana New Zealand wines

Pernod Ricard is pleased to announce that it is retaining its Montana New Zealand wines

Paris cedex 16 -- (MARKET WIRE) -- 10/20/05 -- Press Release - Paris, 19 October 2005 - Pernod Ricard is pleased to announce that it is retaining its Montana New Zealand wine operations following Diageo's decision not to exercise its purchase option. This option had been signed within the framework of an exclusive agreement concluded with Diageo plc in relation to the acquisition of Allied Domecq.

With its high growth range of Montana wines, Pernod Ricard has become the leader in New Zealand wines sold mainly in the United States, the United Kingdom, Australia and New Zealand.

Already established in Australia (Jacob's Creek), Argentina (Etchart, Graffigna), South Africa (Long Mountain) and Spain (Bodegas y Bebidas) ... Pernod Ricard is now the world's N degrees 3 branded wines operator with an nual sales of 23 million cases* and thus extends its portfolio of New World wines.

* Source: IWRS, 2004

For more information, please contact:

Francisco de la VEGA, Communications VP, Tel: +33 (0)1 41 00 40 96

Patrick de BORREDON, Investor Relations VP, Tel: +33 (0)1 41 00 41 71

Florence TARON, Press Relations Manager, Tel: +33 (0)1 41 00 40 88

or visit our web site at www.pernod-ricard.com

This information is provided by CompanynewsGroup


More Stories By Marketwired .

Copyright © 2009 Marketwired. All rights reserved. All the news releases provided by Marketwired are copyrighted. Any forms of copying other than an individual user's personal reference without express written permission is prohibited. Further distribution of these materials is strictly forbidden, including but not limited to, posting, emailing, faxing, archiving in a public database, redistributing via a computer network or in a printed form.